Everest Organics Limited

₹251.25As of Sun 8 Nov 2026, 12:00 UTC
BSE:524790Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 15.34%
Div yield —
ROE 7.63%
Pharmaceutical Preparations
Beta (5Y) 0.48
PE TTM 46.52
TSR TTM (35.89%)
Mkt cap ₹2.440B
ROIC 8.11%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹271
7.79%
(34.60%)
Hold 3|7|4|4|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
2.80
2.95
3.03
3.29
8.86%
20.45%
21.16%
24.44%
Revenue₹M
258.6
269.8
273.0
283.7
13.98%
20.50%
16.26%
14.85%
Peers (US$24.71M)
Cap (US$)
PE
23.28M
12.14x
Capital
TTM
5Y
10Y
Leveragex
0.476
1.314
1.165
EBIT/Intx
0.385
0.240
0.266
Own earn%
(998.17)
(187.40)
(139.32)
Sh yield%
38.35
11.19
12.88
Owners
Insiders/Inst%
5.03
71.24
Short interest%
0.70
SBC / revenue%
2.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
24–27
$1 testx
—
Incr. ROIC%
2